Back
Trinity Biotech PLC Quote, Financials, Valuation and Earnings
Sponsored
TRIB
Sponsored
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
24
TRIB
Trinity Biotech PLC
Last Price:
1.64
Seasonality Move:
8.96%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeTrinity Biotech PLC Price Quote
$1.64
+0.01 (+0.61%)
(Updated: November 12, 2024 at 5:55 PM ET)
Trinity Biotech PLC Key Stats
Sell
24
Trinity Biotech PLC (TRIB)
is a Sell
Day range:
$1.53 - $1.70
52-week range:
$1.05 - $3.55
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.29
P/B ratio:
0%
Volume:
95.6K
Avg. volume:
186.3K
1-year change:
-22.88%
Market cap:
$15.4M
Revenue:
$56.8M
EPS:
$-2.7
How Much Does Trinity Biotech PLC Make?
-
How Much Are Trinity Biotech PLC's Sales Annually?
TRIB Revenues are $56.8M -
How Much Profit Does Trinity Biotech PLC's Make A Year?
TRIB net income is -$24M
Is Trinity Biotech PLC Growing As A Company?
-
What Is Trinity Biotech PLC's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.14% -
What Is Trinity Biotech PLC's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Trinity Biotech PLC Stock Price Performance
-
Did Trinity Biotech PLC Stock Go Up Last Month?
Trinity Biotech PLC share price went down by -18.5% last month -
Did TRIB's Share Price Rise Over The Last Year?
TRIB share price fell by -22.88% over the past 1 year
What Is Trinity Biotech PLC 52-Week High & Low?
-
What Is Trinity Biotech PLC’s 52-Week High Share Price?
Trinity Biotech PLC has traded as high as $3.55 over the past 52 weeks -
What Is Trinity Biotech PLC’s 52-Week Low Share Price?
Trinity Biotech PLC has traded as low as $1.05 over the past 52 weeks
Trinity Biotech PLC Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Trinity Biotech PLC?
-
How Much Debt Does Trinity Biotech PLC Have?
Total long term debt quarterly is $81M -
How Much Cash Does Trinity Biotech PLC Have?
Cash and short term investments quarterly total is $5.3M -
What Is Trinity Biotech PLC’s Book Value Per Share?
Book value per share is -3.11
Is Trinity Biotech PLC Cash Flow Positive?
-
What Is TRIB Cash Flow From Operations?
Cash flow from operations (TTM) is -$8.3M -
What Is Trinity Biotech PLC’s Cash Flow From Financing?
Cash flow from financing (TTM) is $18.6M -
What Is Trinity Biotech PLC’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$18.9M
Trinity Biotech PLC Return On Invested Capital
-
Is Management Doing A Good Job?
TRIB return on invested capital is -52.33% -
What Is Trinity Biotech PLC Return On Assets?
ROA measures how assets are converting to revenues and is -29.36% -
What Is TRIB Return On Equity?
ROE is a measure of profitability and is 0%
Trinity Biotech PLC Earnings Date & Stock Price
-
What Is Trinity Biotech PLC's Stock Price Today?
A single share of TRIB can be purchased today for 1.63 -
What Is Trinity Biotech PLC’s Stock Symbol?
Trinity Biotech PLC trades on the nasdaq under the ticker symbol: TRIB -
When Is Trinity Biotech PLC’s Next Earnings Date?
The next quarterly earnings date for Trinity Biotech PLC is scheduled on January 31, 2025 -
When Is TRIB's next ex-dividend date?
Trinity Biotech PLC's next ex-dividend date is March 11, 2016 -
How To Buy Trinity Biotech PLC Stock?
You can buy Trinity Biotech PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Trinity Biotech PLC Competitors
-
Who Are Trinity Biotech PLC's Competitors?
Below is a list of companies who compete with Trinity Biotech PLC or are related in some way:
Trinity Biotech PLC Dividend Yield
-
What Is TRIB Dividend Yield?
Trinity Biotech PLC’s dividend yield currently is 0% -
What Is Trinity Biotech PLC’s Payout Ratio?
Trinity Biotech PLC’s payout ratio is 0% -
When Did Trinity Biotech PLC Last Pay A Dividend?
The latest dividend pay date is November 13, 2024 -
What Is Trinity Biotech PLC’s Dividend Per Share?
Trinity Biotech PLC pays a dividend of $0.00 per share
Trinity Biotech PLC Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 14% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 15.00 |
Upside from Last Price: | 820.25% |